Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109
Clinical trial NCT01640912 · COMPLETED
Trial details
- NCT number
- NCT01640912
- Sponsor
- RXi Pharmaceuticals, Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.